Panacea, placebo or poison? Genetically guided treatment for depression

Nurmi, Erika L

Nurmi, Erika L.

Nurmi, Erika L; University of California at Los Angeles. Department of Psychiatry and Biobehavioral Sciences. Los Angeles. US

Braz. J. Psychiatry (São Paulo, 1999, Impr.) ; 42(2): 118-119, Mar.-Apr. 2020.

Article in English | LILACS | ID: biblio-1089236

Subject(s)

Humans; Depressive Disorder/genetics; Depressive Disorder/drug therapy; Antidepressive Agents/pharmacology; United States; United States Food and Drug Administration; Placebo Effect; Practice Guidelines as Topic; Pharmacogenomic Testing/standards

Fulltext

XML

Search on Google

Full text: Available Index: LILACS (Americas) Main subject: Depressive Disorder / Antidepressive Agents Type of study: Controlled clinical trial / Practice guideline Limits: Humans Country/Region as subject: North America Language: English Journal: Braz. J. Psychiatry (São Paulo, 1999, Impr.) Journal subject: Psychiatry Year: 2020 Type: Article Affiliation country: United States Institution/Affiliation country: University of California at Los Angeles/US

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google